ArticleAnnals of translational medicine2020

Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial.

Xiang-Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.